Back to search

National and Kapodistrian University of Athens

Αντισώματα έναντι του πρωτέα στην ρευματοειδή αρθρίτιδα

Abstract

dc:description

Objective: The aim of this study was to investigate the existence of antibodies against Proteus Mirabilis in patients with rheumatoid arthritis (RA), because albeit, various environmental and genetic factors were implicated in the expression of RA its causation it is not yet completely determined. Methods: In this study 63 patients with RA and 38 healthy controls were included. Total blood count, PLT, CRP, ESR, RF, solube adhesion molecules (E-selectin, P-selectin, ICAM-1) and class-specific antibodies, IgM, IgG and IgA against three human cross-reactive and non cross-reactive synthetic peptides from Proteus Mirabilis, heamolysin (HpmB), Urease C (UreC) and Urease F (UreF) were performed in all subjects. Likewise, IgA antibodies against of the same peptides of Proteus Mirabilis were performed in urine of all subjects. Anti-peptide autibodies were measured using the ELISA method. Results: Significantly elevated levels – of class specific IgM, IgG and IgA antibodies against the three Proteus peptide were observed among PA patients compared to healthy controls. Specifically, the group of patients with RA had elevated levels of IgM, IgG and IgA antibodies against HpmB peptide and significant difference compared to healthy controls, (P=0,005, P<0,001, P=0,003). Moreover in RA patients elevated levels of IgM, IgG and IgA antibodies were observed against UreC peptide and statistically significant differences compared with control group (P=0,007, P=0,002, P<0,001). Elevated levels of IgM, IgG and IgA antibodies against UreF peptide – which is not presenting cross reactivity with human antigenic peptides – were observed in RA patients and significant differences compared to healthy controls (p=0,007, p<0,001, p<0,001). Raised levels of IgA antibodies against HpmB, UreC and UreF were observed in urine of RA patients and statistically significant differences compared to control group for HpmB and UreF peptides, but not for UreC peptide (p<0,05, p=NS, p<0,05). Anti-peptides antibodies in RA patients showed significant correlation with ERS, CRP, and soluble adhesion molemules, especially when patients divided in subgroups in accordance with the administration treatment. Conclusion: Patients with RA have elevated levels of antibodies against Proteus antigenic epitopes – which are cross – reactive or non cross –reactive with human tissue antigens, this indicate that Proteus is present in the organism of RA patients and triggered immune response in RA patients. Furthermore, the correlation of antipeptide antibodies with the adhesion molecules and inflammatory indices, indicate that antibodies exert damaging cytotoxic effect on joint tissues during the course of the disease.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Χριστόπουλος, Γεώργιος
  • Christopoulos, Georgios

Subjects

dc:subject × 7

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27333

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Χριστόπουλος, Γεώργιος; Christopoulos, Georgios. Αντισώματα έναντι του πρωτέα στην ρευματοειδή αρθρίτιδα. National and Kapodistrian University of Athens, 2010. http://hdl.handle.net/10442/hedi/27333